Form 8-K - Current report:
SEC Accession No. 0001683168-25-007750
Filing Date
2025-10-23
Accepted
2025-10-23 17:00:24
Documents
12
Period of Report
2025-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 28919
  Complete submission text file 0001683168-25-007750.txt   194389

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snoa-20251018.xsd EX-101.SCH 3026
3 XBRL LABEL FILE snoa-20251018_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE snoa-20251018_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 251413710
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)